Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bronchodilator therapy in obstructive lung disease.

E R McFadden

    New England and Regional Allergy Proceedings
    |January 1, 1985
    PubMed
    Summary

    New medications like long-acting beta agonists and sustained-release theophylline simplify obstructive lung disease management. These treatments offer potent relief for acute episodes and better chronic symptom control with fewer side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of obesity on the severity and therapeutic responsiveness of acute episodes of asthma.

    The Journal of asthma : official journal of the Association for the Care of Asthma·2011
    Same author

    Resurrection men and the FEF25-75.

    The Journal of allergy and clinical immunology·2010
    Same author

    Critical comparisons of the clinical performance of oxygen-conserving devices.

    American journal of respiratory and critical care medicine·2010
    Same author

    Safety of binodenoson, a selective adenosine A2A receptor agonist vasodilator pharmacological stress agent, in healthy subjects with mild intermittent asthma.

    Circulation. Cardiovascular imaging·2009
    Same author

    Observations on the physiological interactions between obesity and asthma.

    Journal of applied physiology (Bethesda, Md. : 1985)·2008
    Same author

    Asthma-obesity relationship: association or causality?

    Current allergy and asthma reports·2008

    Area of Science:

    • Pulmonology
    • Pharmacology

    Background:

    • Obstructive lung disease management has advanced significantly.
    • Introduction of novel therapeutic agents has simplified patient care.

    Purpose of the Study:

    • To review recent advancements in the pharmacological management of obstructive lung disease.
    • To highlight the efficacy and benefits of new treatment options.

    Main Methods:

    • Review of current literature on long-acting beta adrenergic agonists, theophylline, and anticholinergic agents.
    • Analysis of their clinical applications in obstructive lung disease.

    Main Results:

    • Highly selective long-acting beta adrenergic agonists are potent and considered first-line for acute airway obstruction.
    • Sustained-release theophylline offers improved symptom control and fewer side effects in chronic disease.
    • New anticholinergic agents show promise for specific clinical scenarios.

    Conclusions:

    • Modern pharmacological agents have greatly simplified the management of obstructive lung disease.
    • These advancements provide more effective and safer treatment options for patients.

    Related Experiment Videos